Skip to content
An Initiative of AVAC In partnership with Access Bridge
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 361 - 370 of 428

Selected Filters:
1 March 2022

Prevention Options for Women Evaluation Research (POWER) Formative Work Report – August 2017

This is a formative work report on the POWER Study, which aimed to characterize choice, uptake, and early adherence to PrEP, and sought to identify cost-effective and scalable delivery models to young women in Kenya and South Africa.

Research

Document
1 March 2022

Prevention Options for Women Evaluation Research Key Informant Interviews Qualitative Report – July 2020

This is a report on Key Informant Interviews undertaken for the POWER Study, which aimed to characterize choice, uptake, and early adherence to PrEP, and sought to identify cost-effective and scalable delivery models to young women in Kenya and South Africa.

Research

Document
15 February 2022

MTN-034 REACH

Archived from the MTN website before it was taken down. Archived MTN-034 news page also available. Primary Objectives To compare the safety profiles of FTC/TDF oral tablet administered daily and dapivirine (25 mg) vaginal matrix ring inserted once every 4 weeks during the first 24 weeks of use of each study product in an adolescent…

Research

1 November 2021

AIDS 2020 Poster – Dapivirine Ring

Poster presented at IAS 2021 attempting to estimate potential demand for the dapivirine vaginal ring across several countries in sub-Saharan Africa.

Research, Supply Chain Management

Document
1 August 2021

Dual Prevention Pill: A Summary of Insights and Recommendations on the uptake of the combined PrEP and Oral Contraceptive pill by women of reproductive age in SA and Zimbabwe”

Slide presentation with recommendations on increasing uptake of a combined oral PrEP and oral contraceptive pill, including specific suggestions for South Africa and Zimbabwe.

Community/Advocacy, Demand Creation/Marketing, Research

Document
1 August 2021

Dual Prevention Pill: The Eureka Workshops Recommendations and Solutions

Slide presentation focused on how best to inform women about the dual prevention pill and instilling confidence that they could take a pill every day.

Community/Advocacy, Research

Document
1 August 2021

Private Sector Analysis for the DPP in Kenya and RSA

Slide presentation discussing the readiness and potential of private sector channels (clinics, pharmacies, doctors' offices) in providing a dual prevention pill in Kenya and South Africa.

Demand Creation/Marketing, Financing & Costing, Research, Service Delivery

Document
1 August 2021

HIV prevention options during pregnancy and breastfeeding – what’s in the pipeline?

Slide presentation given at HIVR4P 2021 providing a broad overview of HIV prevention options for pregnant and breastfeeding populations.

Research

Document
1 March 2021

Test-And-Prevent Analysis: Evaluation of a Pilot Program Linking Clients With Negative HIV Test Results to Pre-exposure Prophylaxis in Zimbabwe

A journal article appearing in Global Health: Science and Practice supporiting clinics offering PrEP to clients receiving negative results to HIV tests.

Research, Testing

Document
1 February 2021

MTN-025

Archived from the MTN website before it was taken down. Primary Objectives Characterize the safety profile associated with the open-label use of the dapivirine (25 mg) vaginal matrix ring (VR) in women Characterize adherence to the open-label use of the dapivirine VR (25 mg) in women Study Summary MTN-025, the HIV Open-label Prevention Extension (HOPE)…

Research